Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Lorenza Di Guardo"'
Autor:
Adele Busico, Monica Rodolfo, Lorenza Di Guardo, Michele Del Vecchio, Licia Rivoltini, Laura Bergamaschi, Viviana Vallacchi, Mario Santinami, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Andrea Devecchi, Matteo Dugo, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Marialuisa Sensi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Durable remissions are observed in 10%–20% of treated patients with advanced metastatic melanoma but the factors associated with long-term complete clinical responses are largely unknown. Here, we report the molecular characteristics of tumor evolu
Externí odkaz:
https://doaj.org/article/6ee6e9735e44433696b169cef2b40458
Autor:
Giulia Vandoni, Federica D'Amico, Marco Fabbrini, Luigi Mariani, Sabina Sieri, Amanda Casirati, Lorenza Di Guardo, Michele Del Vecchio, Andrea Anichini, Roberta Mortarini, Francesco Sgambelluri, Giuseppe Celano, Nadia Serale, Maria De Angelis, Patrizia Brigidi, Cecilia Gavazzi, Silvia Turroni
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 14, p 11611 (2023)
Despite the recent breakthroughs in targeted and immunotherapy for melanoma, the overall survival rate remains low. In recent years, considerable attention has been paid to the gut microbiota and other modifiable patient factors (e.g., diet and body
Externí odkaz:
https://doaj.org/article/c422e294ab7a4c3e9bf4e08017de771d
Autor:
Giovanni Fucà, Mara Lecchi, Chiara Maura Ciniselli, Arianna Ottini, Andrea Spagnoletti, Laura Mazzeo, Daniele Morelli, Paola Frati, Martina Stroscia, Elisabella Ebrahem, Elisa Sottotetti, Giulia Galli, Maria Grazia D’Elia, Riccardo Lobefaro, Monika Ducceschi, Lorenza Di Guardo, Sherrie Bhoori, Salvatore Provenzano, Marco Platania, Monica Niger, Elena Colombo, Federico Nichetti, Matteo Duca, Licia Rivoltini, Roberta Mortarini, Paolo Baili, Giovanni Apolone, Filippo de Braud, Paolo Verderio, Silvia Damian
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Systemic immunosuppression characterizing cancer patients represents a concern regarding the efficacy of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, and real-world evidence is needed to define the effica
Externí odkaz:
https://doaj.org/article/f05777205f62491487f8dae093b20afa
Autor:
Elisabetta Vergani, Matteo Dugo, Mara Cossa, Simona Frigerio, Lorenza Di Guardo, Gianfrancesco Gallino, Ilaria Mattavelli, Barbara Vergani, Luca Lalli, Elena Tamborini, Barbara Valeri, Chiara Gargiuli, Eriomina Shahaj, Marina Ferrarini, Elisabetta Ferrero, Macarena Gomez Lira, Veronica Huber, Michele Del Vecchio, Marialuisa Sensi, Biagio Eugenio Leone, Mario Santinami, Licia Rivoltini, Monica Rodolfo, Viviana Vallacchi
Publikováno v:
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-14 (2020)
Abstract Background Targeted therapy with BRAF and MEK inhibitors has improved the survival of patients with BRAF-mutated metastatic melanoma, but most patients relapse upon the onset of drug resistance induced by mechanisms including genetic and epi
Externí odkaz:
https://doaj.org/article/a1bcbc7c9c6f40e4a638028a386aaac5
Autor:
Daniela Massi, Eliana Rulli, Mara Cossa, Barbara Valeri, Monica Rodolfo, Barbara Merelli, Francesco De Logu, Romina Nassini, Michele Del Vecchio, Lorenza Di Guardo, Roberta De Penni, Michele Guida, Vanna Chiarion Sileni, Anna Maria Di Giacomo, Marco Tucci, Marcella Occelli, Francesca Portelli, Viviana Vallacchi, Francesca Consoli, Pietro Quaglino, Paola Queirolo, Gianna Baroni, Fabrizio Carnevale-Schianca, Laura Cattaneo, Alessandro Minisini, Giuseppe Palmieri, Licia Rivoltini, Mario Mandalà, on behalf of the Italian Melanoma Intergroup
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Clinical response to MAPK inhibitors in metastatic melanoma patients is heterogeneous for reasons still needing to be elucidated. As the patient immune activity contributes to treatment clinical benefit, the pre-existing level of
Externí odkaz:
https://doaj.org/article/11222a07bf7144359f4985d1307f24f9
Autor:
Michele Maio, Lorenza Di Guardo, Veronica Huber, Luca Lalli, Daniele Giardiello, Agata Cova, Paola Squarcina, Paola Frati, Lorenzo Pilla, Marcella Tazzari, Chiara Camisaschi, Flavio Arienti, Chiara Castelli, Valeria Beretta, Licia Rivoltini
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background Myeloid-derived suppressor cells (MDSC), a cornerstone of cancer-related immunosuppression, influence response to therapy and disease outcomes in melanoma patients. Nevertheless, their quantification is far from being integrated into routi
Externí odkaz:
https://doaj.org/article/c2036c43d2894800a68f9e0d32fea1b9
Autor:
Francesco Mannavola, Mario Mandala, Annalisa Todisco, Vanna Chiarion Sileni, Marco Palla, Alessandro Marco Minisini, Laura Pala, Francesca Morgese, Lorenza Di Guardo, Luigia Stefania Stucci, Michele Guida, Alice Indini, Pietro Quaglino, Virginia Ferraresi, Riccardo Marconcini, Maria Chiara Tronconi, Ernesto Rossi, Olga Nigro, Marcella Occelli, Alessio Cortellini, Silvia Quadrini, Giuseppe Palmieri, Jacopo Pigozzo, Paolo Antonio Ascierto, Maria Grazia Vitale, Sabino Strippoli, Pier Francesco Ferrucci, Rossana Berardi, Giovanni Randon, Pietro Cardone, Giovanni Schinzari, Franco Silvestris, Marco Tucci
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundWe performed a multicenter retrospective observational study to investigate the impact of clinical–pathological features and therapeutic strategies on both the complications and survival of patients with bone metastases (BMs) from maligna
Externí odkaz:
https://doaj.org/article/f7e6e5a9fa7d4cde857b7f04aa464c7d
Autor:
Iwona Lugowska, Matilde De Luca, Barbara Merelli, Anna Mariuk-Jarema, Pawel Teterycz, Pawel Rogala, Bożena Cybulska-Stopa, Alice Labianca, Lorenza Di Guardo, Giovanni Randon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Obesity is a risk factor for malignancy; however, its prognostic role in patients with metastatic melanoma is controversial. We aim to investigate the prognostic role of body mass index (BMI) in patients with metastatic melanoma receiving
Externí odkaz:
https://doaj.org/article/8bfef22853f647bdaee885bd165056af
Autor:
Elisabetta Vergani, Simona Frigerio, Matteo Dugo, Andrea Devecchi, Erika Feltrin, Loris De Cecco, Viviana Vallacchi, Mara Cossa, Lorenza Di Guardo, Siranoush Manoukian, Bernard Peissel, Andrea Ferrari, Gianfrancesco Gallino, Andrea Maurichi, Licia Rivoltini, Marialuisa Sensi, Monica Rodolfo
Publikováno v:
Genes, Vol 12, Iss 9, p 1440 (2021)
The MITF-E318K variant has been implicated in genetic predisposition to cutaneous melanoma. We addressed the occurrence of MITF-E318K and its association with germline status of CDKN2A and MC1R genes in a hospital-based series of 248 melanoma patient
Externí odkaz:
https://doaj.org/article/cb964239b0fc4bd4a29c0b00cdd2b6af
Autor:
Luis de la Cruz-Merino, Lorenza Di Guardo, Jean-Jacques Grob, Alfredo Venosa, James Larkin, Grant A. McArthur, Antoni Ribas, Paolo A. Ascierto, Jeffrey T. R. Evans, Antonio Gomez-Escobar, Giulio Barteselli, Susan Eng, Jessie J. Hsu, Anne Uyei, Brigitte Dréno
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Serous chorioretinopathy has been associated with MEK inhibitors, including cobimetinib. We describe the clinical features of serous retinopathy observed with cobimetinib in patients with BRAF V600-mutated melanoma treated in the
Externí odkaz:
https://doaj.org/article/38b41caecf344ca693b0253d6557253d